NEUREN PHARMACEUTICALS LTD NEU.AX :
* FY LOSS ATTRIBUTABLE $10.8 MLN VS PROFIT OF $3.1 MLN
* FY OPERATING REVENUE $1.0 MLN VS $15.2 MLN
NEUREN PHARMACEUTICALS LTD NEU.AX :
* FY LOSS ATTRIBUTABLE $10.8 MLN VS PROFIT OF $3.1 MLN
* FY OPERATING REVENUE $1.0 MLN VS $15.2 MLN